| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.3 | 4e-08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |